These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 9039145

  • 21. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.
    Cachofeiro V, Maeso R, Rodrigo E, Navarro J, Ruilope LM, Lahera V.
    Hypertension; 1995 Aug; 26(2):236-43. PubMed ID: 7635531
    [Abstract] [Full Text] [Related]

  • 22. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S, Patrick SK, Oster L, de Champlain J.
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [Abstract] [Full Text] [Related]

  • 23. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA.
    J Clin Invest; 1997 Apr 15; 99(8):1926-35. PubMed ID: 9109437
    [Abstract] [Full Text] [Related]

  • 24. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses.
    Gohlke P, Stoll M, Lamberty V, Mattfeld T, Mall G, van Even P, Martorana P, Unger T.
    J Hypertens Suppl; 1992 Aug 15; 10(6):S141-4. PubMed ID: 1432317
    [Abstract] [Full Text] [Related]

  • 25. Long-term effects of angiotensin-converting enzyme inhibition on renal medullary neutral lipid in spontaneously hypertensive rats.
    O'Sullivan JB, Harrap SB.
    Hypertension; 1999 May 15; 33(5):1214-7. PubMed ID: 10334814
    [Abstract] [Full Text] [Related]

  • 26. Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment.
    Marin-Castaño ME, Schanstra JP, Neau E, Praddaude F, Pecher C, Ader JL, Girolami JP, Bascands JL.
    Circulation; 2002 Feb 05; 105(5):627-32. PubMed ID: 11827930
    [Abstract] [Full Text] [Related]

  • 27. Angiotensin-converting enzyme inhibition in adult hypertensive rats: a stereological study of renal filtration surface area.
    Dunstan HJ, Briscoe TA, Bertram JF, Johnston CI, Black MJ.
    Clin Exp Pharmacol Physiol; 2003 Feb 05; 30(1-2):72-6. PubMed ID: 12542457
    [Abstract] [Full Text] [Related]

  • 28. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R, Young SD, Strosberg AM.
    J Cardiovasc Pharmacol; 1994 Feb 05; 23(2):291-9. PubMed ID: 7511760
    [Abstract] [Full Text] [Related]

  • 29. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
    Bao G, Gohlke P, Unger T.
    J Cardiovasc Pharmacol; 1992 Feb 05; 20 Suppl 9():S96-9. PubMed ID: 1282637
    [Abstract] [Full Text] [Related]

  • 30. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q, Larouche I, Schiffrin EL.
    Am J Hypertens; 2003 Nov 05; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [Abstract] [Full Text] [Related]

  • 31. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL, Cao Z, Rumble JR, Cooper ME, Johnston CI.
    Am J Hypertens; 1996 Sep 05; 9(9):895-901. PubMed ID: 8879346
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H.
    Circulation; 1997 Apr 01; 95(7):1910-7. PubMed ID: 9107180
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
    Linz W, Wiemer G, Schaper J, Zimmermann R, Nagasawa K, Gohlke P, Unger T, Schölkens BA.
    Mol Cell Biochem; 1997 Apr 01; 147(1-2):89-97. PubMed ID: 7494560
    [Abstract] [Full Text] [Related]

  • 34. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
    Rossi GP, Cavallin M, Rizzoni D, Bova S, Mazzocchi G, Agabiti-Rosei E, Nussdorfer GG, Pessina AC.
    J Hypertens; 2002 Jul 01; 20(7):1451-9. PubMed ID: 12131544
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
    Yayama K, Sugiyama K, Miyagi R, Okamoto H.
    Biol Pharm Bull; 2007 Mar 01; 30(3):591-4. PubMed ID: 17329864
    [Abstract] [Full Text] [Related]

  • 36. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
    Farhy RD, Carretero OA, Ho KL, Scicli AG.
    Circ Res; 1993 Jun 01; 72(6):1202-10. PubMed ID: 7684331
    [Abstract] [Full Text] [Related]

  • 37. Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction.
    Dixon IM, Ju H, Jassal DS, Peterson DJ.
    Mol Cell Biochem; 1996 Dec 06; 165(1):31-45. PubMed ID: 8974079
    [Abstract] [Full Text] [Related]

  • 38. Renal medulla and bradykinin during the development of hypertension in SHR.
    O'Sullivan JB, Bertram JF, Harrap SB.
    Clin Exp Pharmacol Physiol; 1995 Dec 06; 22(6-7):463-5. PubMed ID: 8582104
    [Abstract] [Full Text] [Related]

  • 39. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
    Stauss HM, Zhu YC, Redlich T, Adamiak D, Mott A, Kregel KC, Unger T.
    J Cardiovasc Risk; 1994 Oct 06; 1(3):255-62. PubMed ID: 7621306
    [Abstract] [Full Text] [Related]

  • 40. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K, Gassmann P, Buzello M, Orth SR, Törnig J, Gross ML, Magener A, Mall G, Ritz E.
    Kidney Int; 2000 Jul 06; 58(1):153-61. PubMed ID: 10886560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.